认知行为疗法对首发精神分裂症患者治疗依从性的影响  

The effects of Cognitive Behavior Therapy（CBT） in therapeutic compliance of first-episode schizophrenics

作　　者：万予新 李梅香 马振武 韩嫣 王新法 柴慧 Wan Yuxin;Li Meixiang;Ma Zhenwu;et al（The Second Affiliated Hospital of XinXiang Medical College;Henan 453002;China）

机构地区：新乡医学院第二附属医院,河南新乡453002

出　　处：《中国保健》2006年第07X期15-16,共2页Chinese Health Care

摘　　要：目的：探讨认知行为疗法对首发精神分裂症患者治疗依从性的影响。方法：将首发精神分裂症患者80例,随机分为两组,认知行为治疗组和对照组,两组均采用利培酮治疗。用简明精神病评定量表（BPRS）评定疗效,以及副反应量表（TESS）评定副反应。比较两者的服药依从性。经6个月、1年的随访观察,分别对两组的复发率进行比较。结果：治疗8w后2组疗效无显著性差异。认知行为治疗组完全依从（占67.5%）,显著高于对照组（40%）;不依从（占2.5%）,则显著低于对照组（占22.5%）;6个月、1年后认知行为治疗组复发率低于对照组（P〈0.05～0.01）。结论：认知行为疗法能明显提高首发精神分裂症患者的治疗依从性,减少疾病的复发率。Objective：To explore the effects of Cognitive Behavior Therapy（CBT）in therapeutic compliance of first-episode schizophrenics.Methods：80 first-episode schizophrenics were randomly divided into CBT group and control group,and risperidone was used in two groups individually.Brief Psychiatric Rating Scale（BPRS）and Treatment Emergent Symptoms Scale（TESS）were used to evaluate efficacy and adverse reaction.Recurrent rate of two groups were compared after 6 months and 12 months.Results：After 8 weeks,there was not significant difference in efficacy between two groups,complete compliance of CBT group（67.5%）was higher than control group（40%）significantly.Recurrent rate was lower than control group after 6 months and 12 months（P〈0.05～0.01）.Conclusion：CBT can improve therapeutic compliance of first-episode schizophrenics and reduce recurrant rate.

关 键 词：认知行为疗法 首发精神分裂症 治疗依从性 

分 类 号：R749.3[医药卫生—神经病学与精神病学;医药卫生—临床医学]